VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
McDonald's Corporation vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
McDonald's Corporation
MCD · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into McDonald's Corporation's moat claims, evidence, and risks.
View MCD analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: McDonald's Corporation leads (80 / 100 vs 74 / 100 for Sanofi).
- Segment focus: McDonald's Corporation has 3 segments (48.7% in International Operated Markets); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: McDonald's Corporation has 5 moat types across 2 domains; Sanofi has 5 across 3.
Primary market context
McDonald's Corporation
International Operated Markets
Quick-service restaurants and informal eating out (IEO)
International operated markets (e.g., Australia, Canada, France, Germany, Italy, Poland, Spain, U.K.)
Consumers (end customers) and franchisees (B2B system partners)
Franchisor / restaurant operator
48.7%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
McDonald's Corporation strengths
Sanofi strengths
Segment mix
McDonald's Corporation segments
Full profile >U.S.
Competitive
International Operated Markets
Competitive
International Developmental Licensed Markets & Corporate
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.